A detailed history of Dn B Asset Management As transactions in Annexon, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 74,379 shares of ANNX stock, worth $151,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,379
Previous 47,665 56.05%
Holding current value
$151,733
Previous $244,000 41.39%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$1.93 - $5.5 $51,558 - $146,927
26,714 Added 56.05%
74,379 $143,000
Q4 2024

Feb 12, 2025

BUY
$4.44 - $7.63 $3,822 - $6,569
861 Added 1.84%
47,665 $244,000
Q3 2024

Nov 12, 2024

BUY
$4.49 - $7.2 $1,432 - $2,296
319 Added 0.69%
46,804 $277,000
Q2 2024

Jul 05, 2024

BUY
$4.33 - $6.79 $45,785 - $71,797
10,574 Added 29.45%
46,485 $227,000
Q1 2024

Apr 12, 2024

BUY
$4.03 - $7.81 $144,721 - $280,464
35,911 New
35,911 $257,000
Q2 2023

Jul 06, 2023

BUY
$2.1 - $6.37 $125,021 - $379,231
59,534 New
59,534 $209,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $97.1M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.